Exploiting the immunogenic potential of cancer cells for improved dendritic cell vaccines

Exploiting the immunogenic potential of cancer cells for improved dendritic cell vaccines

Cancer immunotherapy is currently the hottest topic in the oncology field, owing predominantly to the discovery of immune checkpoint blockers. These promising antibodies and their attractive combinatorial features have initiated the revival of other effective immunotherapies like dendritic cell (DC)...

Full description

Bibliographic Details
Main Authors: Lien eVandenberk, Jochen eBelmans, Matthias eVan Woensel, Matteo eRiva, Stefaan Willy Van Gool
Format: Article
Language:English
Published: Frontiers Media S.A. 2016-01-01
Series:Frontiers in Immunology
Subjects:
Immunotherapy
Immunogenic cell death
Immunogenicity
Dendritic Cell vaccines
Tumor lysate
antitumor immunity
Online Access:http://journal.frontiersin.org/Journal/10.3389/fimmu.2015.00663/full

Internet

http://journal.frontiersin.org/Journal/10.3389/fimmu.2015.00663/full

Similar Items